Tissue engineering of heart valves by recellularization of glutaraldehyde-fixed porcine valves using bone marrow-derived cells

Experimental and Molecular Medicine

Volumn 38, Issue 3, 2006, Pages 273-283

  Kim, Sang Soo ^a,b   Lim, Sang Hyun ^c   Seung, Woo Cho ^b   Gwak, So Jung ^a   Hong, Yoo Sun ^d   Byung, Chul Chang ^d   Moon, Hyang Park ^a   Kang, Won Song ^a   Cha, Yong Choi ^b,c   Kim, Byung Soo ^a  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Bone marrow cells; Endothelial cells; Heart valve prosthesis; Tissue engineering

Indexed keywords

ALDEHYDE; ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; CELL NUCLEUS ANTIGEN; CITRIC ACID; GLUTARALDEHYDE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BONE MARROW; CELL ADHESION; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DETOXIFICATION; DOG; ENDOTHELIUM CELL; HEART VALVE; HEART VALVE PROSTHESIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MONONUCLEAR CELL; MYOFIBROBLAST; NONHUMAN; SWINE; TISSUE ENGINEERING;

SUIDAE;

EID: 33745858989     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2006.33     Document Type: Article

References (33)

1. Bengtsson L, Radegran K, Haegerstrand A. In vitro endothelialization of commercially available heart valve bioprostheses with cultured adult human cells. Eur J Cardiothorac Surg 1993;7:393-8
2. Cho SW, Kim IK, Lim SH, Kim DI, Kang SW, Kim SH, Kim YH, Lee EY, Choi CY, Kim BS. Smooth muscle-like tissues engineered with bone marrow stromal cells. Biomaterials 2004;25:2979-86
3. Cho SW, Lim SH, Kim IK, Hong YS, Kim SS, Yoo KJ, Park HY, Jang Y, Chang BC, Choi CY, Hwang KC, Kim BS. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 2005a;241:506-15
4. Cho SW, Park HJ, Ryu JH, Kim SH, Kim YH, Choi CY, Lee MJ, Kim JS, Jang IS, Kim DI, Kim BS. Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices. Biomaterials 2005b;26:1915-24
5. Choi SC, Yoon J, Shim WJ, RO YM, Lim DS. 5-azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med 2004;36:515-23
6. Fischlein T, Fasol R. In vitro endothelialization of bioprosthetic heart valves. J Heart Valve Dis 1996;5:58-65
7. Fischlein T, Lehner G, Lante W, Reichart B. Endothelialization of aldehyde-fixed cardiac valve bioprostheses. Transplant Proc 1992;24:2988
8. Fischlein T, Lehner G, Lante W, Fittkau M, Murphy JG, Weinhold C, Reichart B. Endothelialization of cardiac valve bioprostheses. Int J Artif Organs 1994;17:345-52
9. Flanagan TC, Pandit A. Living artificial heart valve alternatives: a review. Eur Cell Mater 2003;6:28-45
10. Gulbins H, Goldemund A, Anderson I, Haas U, Uhlig A, Meiser B, Reichart B. Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic valves. J Thorac Cardiovasc Surg 2003;125:592-601
11. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102:III44-9
12. Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, Sodian R, Visjager JF, Kolb SA, Grunenfelder J, Zund G, Turina MI. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002;106:I143-50
13. Hoffman D, Gong G, Liao K, Macaluso F, Nikolic SD, Frater RW. Spontaneous host endothelial growth on bioprostheses. Influence of fixation. Circulation 1992;86:II75-9
14. Ishida A, Wu MH, Shi Q, Fujita Y, Sauvage LR, Hammond WP, Wijelath ES. Dynamic changes of smooth muscle and endothelial markers in the early healing process of dacron vascular grafts in the dog, using RT-PCR. Int J Angiol 2000;9:107-10
15. Kadner A, Hoerstrup SP, Zund G, Eid K, Maurus C, Melnitchouk S, Grunenfelder J, Turina MI. A new source for cardiovascular tissue engineering: human bone marrow stromal cells. Eur J Cardiothorac Surg 2002;21:1055-60
16. Kalra M, Jost CJ, Severson SR, Miller VM. Adventitial versus intimal liposome-mediated ex vivo transfection of canine saphenous vein grafts with endothelial nitric oxide synthase gene. J Vasc Surg 2000;32:1190-200
17. Kim BS, Putnam AJ, Kulik TJ, Mooney DJ. Optimizing seeding and culture methods to engineer smooth muscle tissue on biodegradable polymer matrices. Biotechnol Bioeng 1998;57:46-54
18. Liu ML, Hong ST, Early phase of amyloid β42-induced cytotoxicity in neuronal cells is associated with vacuole formation and enhancement of exocytosis. Exp Mol Med 2005;37:559-66
19. Lupinetti FM, Warner J, Jones TK, Herndon SP. Comparison of human tissues and mechanical prostheses for aortic valve replacement in children. Circulation 1997;96:321-5
20. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 2003;24:2303-8
21. Moritz A, Grimm M, Eybl E, Grabenwoger M, Windberger U, Dock W, Bock P, Wolner E. Improved biocompatibility by post-fixation treatment of aldehyde fixed bovine pericardium. ASAIO Trans 1990;36:M300-3
22. Murata M, Kador PF, Sato S. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells. J Ocul Pharmacol Ther 2000;16:383-91
23. Perry TE, Kaushal S, Sutherland FW, Guleserian KJ, Bischoff J, Sacks M, Mayer JE. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Ann Thorac Surg 2003a;75:761-7
24. Perry TE, Roth SJ. Cardiovascular tissue engineering: constructing living tissue cardiac valves and blood vessels using bone marrow, umbilical cord blood, and peripheral blood cells. J Cardiovasc Nurs 2003b;18:30-7
25. Ryu JH, Kim SS, Cho SW, Choi CY, Kim BS. HEK 293 cell suspension culture using fibronectin-adsorbed polymer nanospheres in serum-free medium. J Biomed Mater Res A 2004;71:128-33
26. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valve leaflets: does cell origin affect outcome? Circulation 1997;96:II-102-7
27. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, Moran AM, Kim BS, Schoen FJ, Vacanti JP, Mayer JE Jr. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 2000;102:III22-9
28. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6
29. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T. Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-35
30. Trantina-Yates AE, Human P, Bracher M, Zilla P. Mitigation of bioprosthetic heart valve degeneration through biocompatibility: in vitro versus spontaneous endothelialization. Biomaterials 2001;22:1837-46
31. Weissenstein C, Human P, Bezuidenhout D, Zilla P. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model. J Heart Valve Dis 2000;9:230-40
32. Yacoub M, Rasmi NR, Sundt TM, Lund O, Boyland E, Radley-Smith R, Khaghani A, Mitchell A. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:186-93
33. Zilla P, Fullard L, Trescony P, Meinhart J, Bezuidenhout D, Gorlitzer M, Human P, von Oppell U. Glutaraldehyde detoxification of aortic wall tissue: a promising perspective for emerging bioprosthetic valve concepts. J Heart Valve Dis 1997;6:510-20